Literature DB >> 43480

Specific binding of 3H-adenosine to rat brain membranes.

U Schwabe, H Kiffe, C Puchstein, T Trost.   

Abstract

The binding of 3H-adenosine to rat brain membranes was studied by a microcentrifugation technique. Specific binding of 3H-adenosine was rapid, reversible, saturable and dependent on pH and temperature. Scatchard plots of equilibrium binding data were nonlinear suggesting the existence of two different binding sites for adenosine. The dissociation constants (Kd) were 1.7 muM and 13.6 muM and the maximal number of binding sites (Bmax) 31 and 165 pmol adenosine bound per mg of membrane protein. Ten adenosine derivatives were studied for their ability to compete with 3H-adenosine binding. The phosphorylated adenosine compounds 5'-AMP, cyclic AMP and ATP were most potent in displacing 3H-adenosine from its binding sites and the IC50-values ranged from 11--25 muM. N6-Phenylisopropyladenosine produced only partial inhibition (30%) of 3H-adenosine binding and no stereospecific difference between the (-)- and (+)isomer was observed. Several methylxanthines known as adenosine antagonists competed for the 3H-adenosine binding sites parallel with their pharmacological potency. The results offer a first approach for the study of adenosine binding sites in brain membranes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43480     DOI: 10.1007/bf00499875

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Adenosine release from fat cells: effect on cyclic AMP levels and hormone actions.

Authors:  U Schwabe; R Ebert; H C Erbler
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

2.  Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.

Authors:  R J Haslam; G M Rosson
Journal:  Mol Pharmacol       Date:  1975-09       Impact factor: 4.436

3.  Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis.

Authors:  C Londos; D M Cooper; W Schlegel; M Rodbell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

Review 4.  The control of the metabolism and the hormonal role of adenosine.

Authors:  J R Arch; E A Newsholme
Journal:  Essays Biochem       Date:  1978       Impact factor: 8.000

5.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices.

Authors:  A Sattin; T W Rall
Journal:  Mol Pharmacol       Date:  1970-01       Impact factor: 4.436

6.  Factors influencing the accumulation of cyclic AMP in brain tissue.

Authors:  T W Rall; A Sattin
Journal:  Adv Biochem Psychopharmacol       Date:  1970

Review 7.  Purinergic nerves.

Authors:  G Burnstock
Journal:  Pharmacol Rev       Date:  1972-09       Impact factor: 25.468

8.  Characterization of [3H]adenosine binding to fat cell membranes.

Authors:  C C Malbon; R C Hert; J N Fain
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

9.  Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA).

Authors:  H Vapaatalo; D Onken; P J Neuvonen; E Westermann
Journal:  Arzneimittelforschung       Date:  1975-03

10.  Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin.

Authors:  R H Adamson; D W Zaharevitz; D G Johns
Journal:  Pharmacology       Date:  1977       Impact factor: 2.547

View more
  10 in total

1.  Effects of N-ethylmaleimide on adenosine receptors of rat fat cells and human platelets.

Authors:  D Ukena; E Poeschla; E Hüttemann; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

2.  Biochemical characterization of putative central purinergic receptors by using 2-chloro[3H]adenosine, a stable analog of adenosine.

Authors:  M Williams; E A Risley
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

3.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

4.  Specific [(3)H]-guanosine binding sites in rat brain membranes.

Authors:  Ugo Traversa; Giulia Bombi; Patrizia Di Iorio; Renata Ciccarelli; Eva S Werstiuk; Michel P Rathbone
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

5.  Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine.

Authors:  R F Bruns; J W Daly; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Adenosine receptor agonists: binding and adenylate cyclase stimulation in rat liver plasma membranes.

Authors:  W Schütz; E Tuisl; O Kraupp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

7.  Effect of adenosine on the relaxation of coronary arteries at varying pH values.

Authors:  S J Mustafa; G Ghai
Journal:  Basic Res Cardiol       Date:  1981 Jul-Aug       Impact factor: 17.165

8.  Evidence for an A2 adenosine receptor in guinea pig lung.

Authors:  D Ukena; C G Schirren; K N Klotz; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

9.  The binding of [3H]adenosine to synaptosomal and other preparations from the mammalian brain.

Authors:  M E Newman; J Patel; H McIlwain
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

10.  Adenosine receptors and behavioral actions of methylxanthines.

Authors:  S H Snyder; J J Katims; Z Annau; R F Bruns; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.